We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $8.34B
1-Year Est. Return 165.53%
This Fund
S&P 500
This Quarter Est. Return
+77.9%
1 Year Est. Return
+165.53%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.34B
AUM Growth
+$2.35B
Cap. Flow
-$42M
Cap. Flow %
-0.5%
Top 10 Hldgs %
46.57%
Holding
644
New
20
Increased
132
Reduced
424
Closed
57

Top Sells

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$220M
2
LITE icon
Lumentum
LITE
+$219M
3
TSLA icon
Tesla
TSLA
+$50.1M
4
CIEN icon
Ciena
CIEN
+$43.3M
5
MSFT icon
Microsoft
MSFT
+$42.6M

Sector Composition

Rank Sector Weight
1 Technology 66.11%
2 Communication Services 9.64%
3 Consumer Discretionary 8.42%
4 Industrials 4.35%
5 Healthcare 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMPS
426
Compass Pathways
CMPS
$1.84B
$37.2K ﹤0.01%
2,631
+527
+25% +$5.35K
ABSI icon
427
Absci
ABSI
$1.51B
$36.9K ﹤0.01%
3,184
-178
-5% -$1K
IVT icon
428
InvenTrust Properties
IVT
$2.54B
$36.8K ﹤0.01%
1,040
-134
-11% -$4.4K
AKR icon
429
Acadia Realty Trust
AKR
$2.79B
$36.8K ﹤0.01%
1,758
-223
-11% -$4.77K
URGN icon
430
UroGen Pharma
URGN
$2.16B
$36.5K ﹤0.01%
993
-52
-5% -$1.41K
NVCR icon
431
NovoCure
NVCR
$2.09B
$36.5K ﹤0.01%
2,409
-92
-4% -$1.39K
IOVA icon
432
Iovance Biotherapeutics
IOVA
$3.98B
$36.3K ﹤0.01%
8,716
-199
-2% -$756
FCPT icon
433
Four Corners Property Trust
FCPT
$2.74B
$36.2K ﹤0.01%
1,475
-104
-7% -$2.59K
TYRA icon
434
Tyra Biosciences
TYRA
$1.71B
$36.1K ﹤0.01%
1,131
-67
-6% -$2.22K
INVA icon
435
Innoviva
INVA
$1.54B
$35.5K ﹤0.01%
1,561
-118
-7% -$2.7K
GHRS icon
436
GH Research
GHRS
$1.94B
$35.3K ﹤0.01%
1,315
-69
-5% -$1.44K
FTRE icon
437
Fortrea Holdings
FTRE
$1.68B
$34.5K ﹤0.01%
1,982
-83
-4% -$1.12K
VIR icon
438
Vir Biotechnology
VIR
$1.93B
$33.9K ﹤0.01%
3,327
+216
+7% +$2.06K
DRH icon
439
Diamondrock Hospitality Co
DRH
$2.47B
$33.6K ﹤0.01%
2,756
-343
-11% -$3.73K
HROW icon
440
Harrow
HROW
$1.44B
$33.4K ﹤0.01%
786
-46
-6% -$1.71K
NVAX icon
441
Novavax
NVAX
$1.69B
$32.5K ﹤0.01%
3,449
-184
-5% -$1.65K
SEPN
442
Septerna Inc
SEPN
$1.72B
$31.8K ﹤0.01%
950
-56
-6% -$1.59K
PEB icon
443
Pebblebrook Hotel Trust
PEB
$2.03B
$30.9K ﹤0.01%
1,594
-200
-11% -$3.08K
AVBP icon
444
ArriVent BioPharma
AVBP
$1.53B
$30.5K ﹤0.01%
877
-42
-5% -$1.24K
MAZE
445
Maze Therapeutics
MAZE
$1.46B
$30.5K ﹤0.01%
1,021
-59
-5% -$1.55K
MPT
446
Medical Properties Trust
MPT
$2.39B
$30.4K ﹤0.01%
6,574
-1,150
-15% -$5.7K
PSNL icon
447
Personalis
PSNL
$1.84B
$29.7K ﹤0.01%
2,214
+232
+12% +$1.89K
INBX icon
448
Inhibrx
INBX
$1.78B
$29.6K ﹤0.01%
312
-14
-4% -$1.4K
IMCR icon
449
Immunocore
IMCR
$1.86B
$29.5K ﹤0.01%
929
-51
-5% -$1.51K
ZBIO
450
Zenas BioPharma
ZBIO
$2.14B
$28.9K ﹤0.01%
1,138
-67
-6% -$1.33K

Similar funds

GF Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, GF Fund Management held 644 positions worth $8.34B, up 39% from $5.98B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

GF Fund Management's Q2 2026 filing shows 20 new, 132 increased, 424 reduced and 57 closed positions. Its largest new stake was INNIO N.V.: 4,970,000 shares worth $197M. The largest sale was Tower Semiconductor, an estimated $220M.

By sector, the portfolio is most concentrated in Technology at 66% of assets, up from 54% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q2 2026 buy was INNIO N.V.: 4,970,000 shares worth $197M.
  • GF Fund Management added most to Advanced Micro Devices in Q2 2026, an estimated $119M increase.
  • GF Fund Management's biggest Q2 2026 reduction was Tower Semiconductor, cutting an estimated $220M.
  • GF Fund Management fully exited Coherent in Q2 2026, selling an estimated $23.3M.
  • GF Fund Management's ten largest holdings make up 47% of its $8.34B portfolio in Q2 2026.
  • GF Fund Management opened 20 new positions and closed 57 in Q2 2026.
  • GF Fund Management's portfolio value rose 39% quarter-over-quarter to $8.34B.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.